Cadence Capital Management’s AtriCure ATRC Stock Holding History

Cadence Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-36,303	Closed	-$795K	–	610
2015 Q3	$795K	Sell	36,303 -30,487	-46%	-$762K	0.06%	362
2015 Q2	$1.65M	Sell	66,790 -1,700	-2%	-$38K	0.09%	275
2015 Q1	$1.4M	Buy	68,490 +640	+0.9%	+$12.4K	0.09%	300
2014 Q4	$1.35M	Buy	+67,850	New	+$1.16M	0.08%	322

Other funds holding ATRC

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Cadence Capital Management's ATRC Position: Q4 2015 in Review

Cadence Capital Management sold out of AtriCure (ATRC) in Q4 2015, closing a stake of 36,303 shares — an estimated $795K sold.

Cadence Capital Management first reported a position in ATRC in Q4 2014 and held it in 4 quarters. The position peaked at $1.65M in Q2 2015. 118 funds tracked by Wall St. Rank hold ATRC as of Q4 2015.

Cadence Capital Management reported no remaining AtriCure position as of Q4 2015 after selling out during the quarter.
Cadence Capital Management sold 36,303 AtriCure shares in Q4 2015, an estimated $795K.
Cadence Capital Management first reported a position in AtriCure in Q4 2014 and held it in 4 quarters.
Cadence Capital Management's AtriCure position peaked at $1.65M in Q2 2015.
118 funds tracked by Wall St. Rank held AtriCure as of Q4 2015.

Based on Cadence Capital Management's 13F filing for Q4 2015, filed 3 Feb 2016.